Groupe d'Etude en Oncologie du Quebec

Title	A Randomized Controlled Trial of Endoscopic Ultrasound Guided Celiac Plexus Neurolysis (EUS-CPN) With and Without Bupivacaine
Protocole ID	21.151
ClinicalTrials.gov ID	NCT04951804
Cancer Type(s)	Pancreas
Phase	Other
Stage
Study Type	Clinical
Drug	Neurolyse du plexus cœliaque guidé par échographie endoscopique avec ou sans bupivacaine
Institution	CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
City
Principal Investigator	Dr. Anand Sahai
Coordinator	Charles Mackay 514-890-8000 poste 36484
Status	Recruiting
Activation Date	01-08-2022
Eligibility Criteria	Malignant-appearing pancreatic mass, or proven pancreatic cancer involving the pancreatic genu, body, or tail Any level of abdominal or back pain considered to be potentially related to the mass: New onset pain (<3 months) Constant Centrally located With or without irradiation to the back No obvious other source of pain based on history and physical examination by the attending endosonographer No possibility of surgical management Signed, informed consent Celiac axis accessible for bilateral neurolysis at EUS.
Exclusion Criteria	Allergy to bupivacaine

Groupe d'étude en oncologie du Québec